<div class="container">

<table style="width: 100%;"><tr>
<td>sebor</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Seborrheic Dermatitis Data</h2>

<h3>Description</h3>

<p>The data are from a randomized clinical trial to compare a test treatment to placebo for a seborrheic dermatitis, and listings of the data appear in Ramaswamy, Koch, and Amara (1997).
The variables are as follows:
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(sebor)
</code></pre>


<h3>Format</h3>

<p>A data frame with 167 observations and 8 variables.
</p>


<h3>Details</h3>


<dl>
<dt><code>center</code></dt>
<dd>
<p>a factor vector for eight centers</p>
</dd>
<dt><code>treat</code></dt>
<dd>
<p>a factor with levels <code>placebo</code> and <code>test</code> for placebo and test treatments, resectively</p>
</dd>
<dt><code>score1</code></dt>
<dd>
<p>a numeric vector for patient global scores for the face according to 6 categories (0 = cleared, 1 = excellent improvement, 2 = moderate improvement, 3 = slight improvement, 4 = no change, 5 = exacerbation)</p>
</dd>
<dt><code>score2</code></dt>
<dd>
<p>a numeric vector for patient global scores for the scalp with same categories as <code>score1</code></p>
</dd>
<dt><code>score3</code></dt>
<dd>
<p>a numeric vector for patient global scores for the chest with same categories as <code>score1</code></p>
</dd>
<dt><code>severity1</code></dt>
<dd>
<p>a numeric vector for the baseline desease severity for the face according to 3 categories (1 = mild, 2 = moderate, 3 = severe)</p>
</dd>
<dt><code>severity2</code></dt>
<dd>
<p>a numeric vector for the baseline desease severity for the scalp with same categories as <code>severity1</code></p>
</dd>
<dt><code>severity3</code></dt>
<dd>
<p>a numeric vector for the baseline desease severity for the chest with same categories as <code>severity1</code></p>
</dd>
</dl>
<h3>References</h3>

<p>Ramaswamy R, Koch G, Amara I (1997). "Application of rank analysis of covariance methods to analysis of multiple anatomical regions with treatment for seborrheic dermatitis." Journal of Biopharmaceutical Statistics, 7(3), 403â€“416.
</p>


</div>